期刊文献+

冠心病患者的脂蛋白(a)及其它相关危险因素(194例)分析 被引量:9

在线阅读 下载PDF
导出
摘要 目的:探讨冠心病患者脂蛋白(a)〔Lp(a)〕与总胆固醇(TC)、血糖(GLU)及低密度脂蛋白(LDL)等危险因素的相关性。方法:冠心病患者共194例,其中心绞痛73例,男性37例,女性36例;急性心肌梗死121例,男性61例,女性60例。测定194例冠心病患者Lp(a)与TC、GLU及LDL水平。结果:冠心病患者的Lp(a)与TC及LDL之间具有正相关(r=0.440,P=0.009;r=0.314,P=0.01);而与GLU呈负相关(根据散点图有负相关趋势,但未达到显著差异(r=-0.044,P=0.321),其中更多急性心肌梗死者Lp(a)升高更明显较正常患者发生例数高,2组急性心肌梗死患病率比较差异有统计学意义(P<0.05)。结论:Lp(a)是冠心病患者的危险因素检测指标之一,联合测定其它危险因素指标有利于冠心病患者的预测、诊断及预后。
出处 《心肺血管病杂志》 CAS 2009年第4期280-281,F0003,共3页 Journal of Cardiovascular and Pulmonary Diseases
作者简介 通讯作者
  • 相关文献

参考文献7

  • 1徐军,李露言,李检春,庄一义,许平,汪俊军.脂蛋白(a)在冠心病患者中的动态变化及其意义[J].心肺血管病杂志,1993,12(2):102-103. 被引量:2
  • 2李悦纯,陆国平.脂蛋白(a)与冠心病的研究[J].国际心血管病杂志,2007,34(6):405-408. 被引量:8
  • 3D'Angelo A, Ruotolo G, Garancini P, et al. Lipoprotein ( a), fibrinogen and vascular mortality in an elderly northern Italian population. Haematologica, 2006, 91:1613-1620.
  • 4Lima LM, Carvalho MG, Loures-Vale AA, et al. Increased serum levels of lipoprotein(a) correlated with the severity of coronary artery disease in patients submitted to angiography. Arq Bras Cardiol, 2006, 87:260-266.
  • 5吕晋琳,杨丽霞,齐峰,石燕昆,苗贵华,王红.血清胆红素与血脂及冠状动脉病变程度相关性研究[J].心肺血管病杂志,2008,27(4):218-220. 被引量:3
  • 6Barlera S, Specchia C, Farrall M, et al. Multiple QTL influence the serum Lp (a) concentration : a genome-wide linkage screen in the PROCARDIS study. Eur J Hum Genet, 2007, 15:221-227.
  • 7Jones GT, van Rij AM, Cole J, et al. Lipoprotein(a) indicates Risk for 4 distinct forms of vascular disease. Clin Chem, 2007, 53:679-685.

二级参考文献26

  • 1周业模,马晓茹,王联霞.探讨脂蛋白a及其临床意义[J].现代保健,2006(01X):88-89. 被引量:1
  • 2[3]Berglund L,Ramakrishnan R.Lipoprotein(a):a elusive cardiovascular risk factor[J].Arterioscler Thromb Vasc Biol,2004,24(12):2219 -2226.
  • 3[4]Demant T,Seeberg K,Bedynek A,et al.The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins:a kinetic study in humans[J].Atherosclerosis,2001,157(2):325-339.
  • 4[6]Hancock MA,Boffa MB,Marcovina SM,et al.Inhibition of plasminogen activation by lipoprotein(a):critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces[J].J Biol Chem,2003,278 (26):23260-23269.
  • 5[7]Skeldal S,Larsen JV,Pedersen KE,et al.Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family,determined by site-directed mutagenesis[J].FEBS,2006,273(22):5143-5159.
  • 6[11]Iwamoto T,Fukuda S,Shinizu S,et al.Long-term effects of lipoprotein(a) on carotid atherosclerosis in elderly japanese[J].Biol Sci Med Sci,2004,59(1):62-67.
  • 7[12]Gazzaruso C,Bruno R,Pujia A,et al.Lipoprotein(a),apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients[J].Int J Cardiol,2006,108(3):354-358.
  • 8[14]Hartmann M,Mintz GS,Stotl MG,et al.Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries[J].J Am Coll Cardiol,2006,48 (3):446-452.
  • 9[16]Moon JY,Kwon HM,Kwon SW,et al.Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease[J].Cardiology,2007,108(4):282-289.
  • 10[17]Austin MA,Hutter CM,Zimmern RL,et al.Familial hypercholesterolemia and coronary heart disease:a huge association review[J].Am J Epidemiol,2004,160(5):421-429.

共引文献9

同被引文献65

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部